NLRP3 inflammasome activation involved in LPS and coal tar pitch extract‐induced malignant transformation of human bronchial epithelial cells

Inflammatory microenvironment has been found as a new characteristic of cancer; however, the mechanisms of inflammation‐related lung cancer remain unclear. To explore the role of NLRP3 inflammsome activation in inflammation‐related lung carcinogenesis, a cell model was set up. Human bronchial epithelial cells (BEAS‐2B) were stimulated with 1 μg/mL lipopolysaccharide (LPS) for 24 hours, and then treated with 2.4 μg/mL coal tar pitch extract (CTPE) for 24 hours, after removal of LPS and CTPE, the cells were numbered passage 1 and were passaged and treated in this way until passage 30, which was called LPS + CTPE group. DMSO and Saline were used as vehicle controls. Malignant transformation of cells in passage 30 was evaluated by morphological change, platelet clone formation assay, and tumor formation in nude mice. The mRNA levels of NLRP3 and IL‐1β were detected by real time‐PCR. The combination of NLRP3 and caspase‐1 were determined using immunofluorescence and confocal. The protein expression of NLRP3, cleaved caspase‐1(p10), and cleaved IL‐1β was detected using Western blot. It was shown that CTPE, LPS + CTPE‐stimulated BEAS‐2B cells of passage 30 changed a lot morphologically. The clone formation rates, the rates of positive cells of NLRP3 and caspase‐1 combination, the mRNA levels of NLRP3 and IL‐1β, the protein expression of NLRP3, cleaved caspase‐1(p10) and cleaved IL‐1β of cells exposed with CTPE and LPS + CTPE at passage 30 were significantly increased compared to vehicle controls. Furthermore, the ability of tumor formation in nude mice, the rates of clone formation and positive cells, mRNA and protein levels of NLRP3 inflammasome activation‐related factors in LPS + CTPE‐induced cells were all higher than those in cells stimulated with CTPE alone. In conclusion, the cell model of inflammation‐related lung cancer is set up successfully, and NLRP3 inflammasome activation may be involved in the malignant transformation of BEAS‐2B cells which induced by CTPE alone or LPS combined with CTPE.

[1]  P. Aukrust,et al.  NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction. , 2018, American journal of physiology. Endocrinology and metabolism.

[2]  Xiaoping Zhou,et al.  Tripartite motif‐containing 37 (TRIM37) promotes the aggressiveness of non‐small‐cell lung cancer cells by activating the NF‐κB pathway , 2018, The Journal of pathology.

[3]  E. Alnemri,et al.  SUMO-mediated regulation of NLRP3 modulates inflammasome activity , 2018, Nature Communications.

[4]  E. Latz,et al.  Targeting the NLRP3 inflammasome in inflammatory diseases , 2018, Nature Reviews Drug Discovery.

[5]  W. Su,et al.  NLRP3 inflammasome: A likely target for the treatment of allergic diseases , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  Yuanlin Zhou,et al.  Hemin Induces the Activation of NLRP3 Inflammasome in N9 Microglial Cells. , 2018, Iranian journal of immunology : IJI.

[7]  Jiang Li,et al.  NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma , 2018, BMC Cancer.

[8]  S. R. Kopalli,et al.  NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents. , 2018, Recent patents on anti-cancer drug discovery.

[9]  N. Lu,et al.  Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy , 2018, Oncoimmunology.

[10]  Z. Fu,et al.  Polymeric Nanoparticles Induce NLRP3 Inflammasome Activation and Promote Breast Cancer Metastasis. , 2017, Macromolecular bioscience.

[11]  Dan Yang,et al.  LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment. , 2017, Cancer letters.

[12]  G. Miller,et al.  NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma , 2017, The Journal of experimental medicine.

[13]  Hui-Ann Wu,et al.  Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3 Signaling Pathways , 2017, Inflammation.

[14]  Si Ming Man,et al.  Inflammasomes and Cancer , 2017, Cancer Immunology Research.

[15]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[16]  K. Yanagihara,et al.  Induction of apoptosis by HBI‐8000 in adult T‐cell leukemia/lymphoma is associated with activation of Bim and NLRP3 , 2016, Cancer science.

[17]  M. Sayan,et al.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases , 2015, Particle and Fibre Toxicology.

[18]  M. Capogrossi,et al.  MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma , 2015, Clinical Epigenetics.

[19]  F. Kassie,et al.  Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators. , 2015, Carcinogenesis.

[20]  Hong Wang,et al.  Differential expression of inflammasomes in lung cancer cell lines and tissues , 2015, Tumor Biology.

[21]  Yian Wang,et al.  Dietary Diindolylmethane Suppresses Inflammation-Driven Lung Squamous Cell Carcinoma in Mice , 2014, Cancer Prevention Research.

[22]  Mo-Fang Liu,et al.  IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. , 2014, Cancer research.

[23]  James H Doroshow,et al.  Molecular mechanisms underlying chronic inflammation-associated cancers. , 2014, Cancer letters.

[24]  J. Vince,et al.  Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? , 2014, Biochimica et biophysica acta.

[25]  Jian-feng Dong,et al.  Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer , 2014, Medical Oncology.

[26]  D. Powell,et al.  Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock , 2013, Science.

[27]  M. T. Wong,et al.  Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4 , 2013, Science.

[28]  M. G. O’Sullivan,et al.  Lipopolysaccharide Enhances Mouse Lung Tumorigenesis , 2013, Veterinary pathology.

[29]  Weidong Wu,et al.  Macrophages Facilitate Coal Tar Pitch Extract-Induced Tumorigenic Transformation of Human Bronchial Epithelial Cells Mediated by NF-κB , 2012, PloS one.

[30]  R. Field,et al.  Occupational and environmental causes of lung cancer. , 2012, Clinics in chest medicine.

[31]  Demosthenes Bouros,et al.  Lung Cancer and Interstitial Lung Diseases: A Systematic Review , 2012, Pulmonary medicine.

[32]  D. Sin,et al.  The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. , 2012, The Journal of allergy and clinical immunology.

[33]  Yongjun Wu,et al.  Analysis of coal tar pitch and smoke extract components and their cytotoxicity on human bronchial epithelial cells. , 2011, Journal of hazardous materials.